$13.42
-0.70-4.96%
Last update: Nov 6, 4:00 PM
Integra Lifesciences Holdings Corp
IARTNASDAQ
The average analyst price target for Integra Lifesciences is $20.43, 52.2% above the current price. Of 13 analysts, 4 rate it Buy, 6 Hold and 3 Sell. Targets range from $12 to $50. The latest change came on Oct 27, 2026, when UBS lowered its price target on Integra Lifesciences from $19 to $14 and kept a Neutral rating.
Price Target Range — 12 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
